These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 14460349)
1. Central nervous system effects of thalidomide. KUHN WL; VAN MAANEN EF J Pharmacol Exp Ther; 1961 Oct; 134():60-8. PubMed ID: 14460349 [No Abstract] [Full Text] [Related]
2. Neuropathy after intake of thalidomide (distaval). FULLERTON PM; KREMER M Br Med J; 1961 Sep; 2(5256):855-8. PubMed ID: 13702560 [No Abstract] [Full Text] [Related]
3. Pharmacological properties of thalidomide (alpha-phthalimido glutarimide), a new sedative hypnotic drug. SOMERS GF Br J Pharmacol Chemother; 1960 Mar; 15(1):111-6. PubMed ID: 13832739 [TBL] [Abstract][Full Text] [Related]
4. [Electroencephalographic observations during the use of thalidomide]. ROTH G Nervenarzt; 1962 Mar; 33():130-3. PubMed ID: 14494378 [No Abstract] [Full Text] [Related]
5. [Changes in the blood of chicks under the influence of thalidomide]. KEMPER F; BERGER H Z Gesamte Exp Med; 1962; 136():86-96. PubMed ID: 14455091 [No Abstract] [Full Text] [Related]
7. [The effect of thalidomide on growth and sexual development of the cock]. KEMPER F Z Gesamte Exp Med; 1962; 135():454-9. PubMed ID: 14455095 [No Abstract] [Full Text] [Related]
8. 6-Aminonicotinamide, a central nervous system depressant. REDETZKI HM; ALVAREZ-O'BOURKE F J Pharmacol Exp Ther; 1962 Aug; 137():173-8. PubMed ID: 14490930 [No Abstract] [Full Text] [Related]
9. [Sleep activation of the EEG with a barbiturate-free drug (thalidomide)]. KUGLER J; FINCKH R Psychiatr Neurol (Basel); 1962; 143():45-54. PubMed ID: 14460306 [No Abstract] [Full Text] [Related]
10. A new series of central depressants: N-alkylaryl camphidines. HERMANSEN K Acta Pharmacol Toxicol (Copenh); 1960; 17():277-87. PubMed ID: 13713638 [No Abstract] [Full Text] [Related]
11. Comparison of physostigmine and amphetamine in antagonizing the EEG effects of CNS depressants. WHITE RP; BOYAJY LD Proc Soc Exp Biol Med; 1959 Nov; 102():479-83. PubMed ID: 13844396 [No Abstract] [Full Text] [Related]
12. Neuropathy, hypoglycaemia, and adrenal dysfunction during treatment with thalidomide. YORKE RA; SUTTON WS; KILSHAW D; TAYLOR WH Br Med J; 1962 Aug; 2(5300):306-7. PubMed ID: 14009207 [No Abstract] [Full Text] [Related]
14. [EXPERIMENTAL CHRONAXIMETRIC STUDY OF SEVERAL PSYCHOTROPIC AGENTS AND OF THEIR ACTION ON THE NERVOUS EFFECTS OF ETHYL ALCOHOL. I. SEDATIVES, ANALGESICS AND HYPNOTICS]. LECOQ R; CHAUCHARD P; MAZOUE H Therapie; 1964; 19():967-74. PubMed ID: 14190953 [No Abstract] [Full Text] [Related]
15. [Electroclinical crisis due to Megimide and the activation of the electroencephalogram with various sedatives and hypnotics. Comparative study in epileptics]. MARTIN F; CHARGHI A Schweiz Arch Neurol Neurochir Psychiatr; 1962; 89():72-93. PubMed ID: 14470362 [No Abstract] [Full Text] [Related]
16. [ROLE OF SOME SEGMENTS OF THE NERVOUS SYSTEM IN THE MECHANISM OF ACTION OF STIMULATING AND DEPRESSIVE DRUGS]. ARBUZOV SIa; NIKIFOROV MI Farmakol Toksikol; 1964; 27():746-50. PubMed ID: 14321313 [No Abstract] [Full Text] [Related]
17. [Effects of 3-methyl-1-pentyle-3-ol carbamate (N-oblivon) on nerve centers]. CHAUCHARD P; MAZOUE H C R Seances Soc Biol Fil; 1956 Sep; 150(4):679-80. PubMed ID: 13365175 [No Abstract] [Full Text] [Related]
18. [NEW THIOXANTHENIC DERIVATIVES WITH CENTRAL NERVOUS SYSTEM ACTIVITY]. CATTANEO A; GELMI G; JORI A; ZEVIO H Farmaco Sci; 1963 Sep; 18():643-52. PubMed ID: 14089668 [No Abstract] [Full Text] [Related]
19. Studies on central nervous system depressants. I. General pharmacological properties of trimeglamide. SHARMA JD; DANDIYA PC Arch Int Pharmacodyn Ther; 1962 May; 137():218-30. PubMed ID: 13911366 [No Abstract] [Full Text] [Related]
20. [Apropos of abnormalities attributed to a somnifacient: thalidomide]. TUCHMANN-DUPLESSIS H Presse Med (1893); 1962 Jun; 70():1521-2. PubMed ID: 13922984 [No Abstract] [Full Text] [Related] [Next] [New Search]